Dexpramipexole structure
|
Common Name | Dexpramipexole | ||
---|---|---|---|---|
CAS Number | 104632-28-2 | Molecular Weight | 211.331 | |
Density | 1.17±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C10H17N3S | Melting Point | 270-272ºC | |
MSDS | N/A | Flash Point | N/A |
Use of DexpramipexoleDexpramipexole(KNS-760704), also known as R-(+)-Pramipexole, is a neuroprotective agent and weak non-ergoline dopamine agonist. IC50 Value:Target: Dopamine ReceptorDexpramipexole has been found to have neuroprotective effects and is being investigated for treatment of amyotrophic lateral sclerosis (ALS). Dexpramipexole reduces mitochondrial reactive oxygen species (ROS) production, inhibits the activation of apoptotic pathways, and increase cell survival in response to a variety of neurotoxins and β-amyloid neurotoxicity. Compared to the S-(-) isomer, Dexpramipexole has much lower dopamine agonist activity. |
Name | (6R)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine |
---|---|
Synonym | More Synonyms |
Description | Dexpramipexole(KNS-760704), also known as R-(+)-Pramipexole, is a neuroprotective agent and weak non-ergoline dopamine agonist. IC50 Value:Target: Dopamine ReceptorDexpramipexole has been found to have neuroprotective effects and is being investigated for treatment of amyotrophic lateral sclerosis (ALS). Dexpramipexole reduces mitochondrial reactive oxygen species (ROS) production, inhibits the activation of apoptotic pathways, and increase cell survival in response to a variety of neurotoxins and β-amyloid neurotoxicity. Compared to the S-(-) isomer, Dexpramipexole has much lower dopamine agonist activity. |
---|---|
Related Catalog | |
References |
Density | 1.17±0.1 g/cm3 |
---|---|
Melting Point | 270-272ºC |
Molecular Formula | C10H17N3S |
Molecular Weight | 211.331 |
PSA | 83.52000 |
LogP | 4.38490 |
Water Solubility | Slightly soluble (1.1 g/L) (25 ºC) |
Hazard Codes | Xi |
---|---|
HS Code | 2934999090 |
~% Dexpramipexole CAS#:104632-28-2 |
Literature: WO2013/96816 A1, ; Paragraph 000145-000146 ; |
~% Dexpramipexole CAS#:104632-28-2 |
Literature: Journal of Medicinal Chemistry, , vol. 30, # 3 p. 494 - 498 |
~% Dexpramipexole CAS#:104632-28-2 |
Literature: WO2010/22140 A1, ; Page/Page column 100-101 ; |
~% Dexpramipexole CAS#:104632-28-2 |
Literature: Journal of Medicinal Chemistry, , vol. 30, # 3 p. 494 - 498 |
~% Dexpramipexole CAS#:104632-28-2 |
Literature: Journal of Medicinal Chemistry, , vol. 30, # 3 p. 494 - 498 |
~0% Dexpramipexole CAS#:104632-28-2 |
Literature: GENERICS [UK] LIMITED Patent: WO2006/3471 A2, 2006 ; Location in patent: Page/Page column 9-11 ; |
HS Code | 2934999090 |
---|---|
Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Dexpramipexole |
(6R)-2-amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole |
(R)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine |
(6R)-4,5,6,7-tetrahydro-N6-propylbenzothiazole-2,6-diamine |
(R)-Pramipexole Dihydrochloride |
Pramipexole [USAN:INN] |
(R)-(+)-2-amino-4,5,6,7-tetrahydro-6-(n-propylamino)benzothiazole |
(R)-Pramipexole |
(R)-(+)-pramipexole |